RAP1 Antikörper (C-Term) (FITC)
-
- Target Alle RAP1 (TERF2IP) Antikörper anzeigen
- RAP1 (TERF2IP) (Telomeric Repeat Binding Factor 2, Interacting Protein (TERF2IP))
-
Bindungsspezifität
- AA 348-378, C-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser RAP1 Antikörper ist konjugiert mit FITC
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human
- Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
- Produktmerkmale
- TERF2IP, CT (TERF2IP, DRIP5, RAP1, Telomeric repeat-binding factor 2-interacting protein 1, Dopamine receptor-interacting protein 5, Repressor/activator protein 1 homolog) (FITC)
- Aufreinigung
- Purified by Protein A affinity chromatography.
- Immunogen
- TERF2IP antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 348-378 amino acids from the C-terminal region of human TERF2IP.
- Isotyp
- IgG
- Top Product
- Discover our top product TERF2IP Primärantikörper
-
-
- Applikationshinweise
- Optimal working conditions should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Supplied as a liquid in PBS, pH 7.2.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C
-
- Target
- RAP1 (TERF2IP) (Telomeric Repeat Binding Factor 2, Interacting Protein (TERF2IP))
- Andere Bezeichnung
- TERF2IP (TERF2IP Produkte)
- Synonyme
- DRIP5 antikoerper, RAP1 antikoerper, Rap1 antikoerper, cRAP1 antikoerper, TERF2 interacting protein antikoerper, telomeric repeat binding factor 2, interacting protein antikoerper, TERF2IP antikoerper, Terf2ip antikoerper
- NCBI Accession
- NP_061848
- UniProt
- Q9NYB0
- Pathways
- Zellzyklus, Telomere Maintenance
-